The influence of superdisintegrant choice on the rate of drug dissolution

Pharmaceutical Technology Europe

Volumn 21, Issue 9, 2009, Pages 44-49

  Balasubramaniam, Jagdish ^a   Bee, Tim ^b  

^a Pharmaceutical R and D   (India)

^b INTERNATIONAL SPECIALTY PRODUCTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ATORVASTATIN; CARBAMAZEPINE; CLOPIDOGREL; CROSCARMELLOSE SODIUM; CROSPOVIDONE; EFAVIRENZ; EZETIMIBE; KETOCONAZOLE; LORATADINE; NEVIRAPINE; PIROXICAM; RALOXIFENE; SIMVASTATIN; STARCH GLYCOLATE SODIUM; TERBINAFINE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; PARTICLE SIZE; SURFACE PROPERTY;

EID: 70349679143     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. J.R. Johnson et al., J. Pharm. Sci., 80(5), 469-471 (1991).
2. J.K. Pandit, M.K. Tripathi and R.J. Babu, Pharmazie, 52(7), 538-540 (1997).
3. A. Sakr, M. Bose and A. Menon, Pharm. Ind., 55(10), 953-957 (1993).
4. US Pharmacopeia, USP 31-NF 26 (2008).
5. S.A. Qureshi, Dissolution Technologies, 13(4), 18-23 (2006)